Share:
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has closed its previously announced acquisition (the "
Acquisition") of Integrated Rehab and Performance Ltd. ("
IRP"). Pursuant to the terms of the definitive agreement (the "
Agreement"), Ketamine One has acquired 100% of the outstanding and issued shares of IRP (the "
Transaction") and IRP's Founder and Chief Executive Officer ("
CEO"), Steven Inglefield, has become a director of Ketamine One.